Denmark - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases

Since 2014, Denmark Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases was up 32% year on year. In 2019, the country was number 280 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 4 Cases. India lead the ranking with 66,255 Cases in 2019, an increase of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.

Loading...

Date Units (Cases)
2019 4.00
2018
2017
2016
2015
Download all data from 2005 to 2019

How does Denmark rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?

# 359 Countries Units (Cases) Last YoY 5‑years CAGR
1 #1
India
66,255 2019 +13.6 % +20.8 % View data
3 #3
Russia
29,181 2019 +5.0 % +13.4 % View data
280 #280
Costa Rica
4 2019 +0.0 % +31.9 % View data
280 #280
Denmark
4 2019 NA +31.9 % View data
280 #280
Greece
4 2014 -79.0 % -21.0 % View data
Compare all 359 countries

Go Top